Petmed Express INC Form 4 insider transactions

Leslie C.G. Campbell, Interim CEO and President and a Director of Petmed Express Inc, received 60,000 shares of common stock on August 11, 2026.

James Lacamp, a Director of Petmed Express Inc, received 55,555 shares of common stock on August 11, 2026.

Peter Batushansky, a Director of Petmed Express Inc, received 55,555 shares of common stock on August 11, 2026.

Justin L. Mennen, a Director of Petmed Express Inc, received 55,555 shares of common stock on August 11, 2026.

Douglas Krulik, CAO and Interim CFO of Petmed Express Inc, reported multiple transactions in common stock on June 26, 2026.

Douglas Krulik, CAO and Interim CFO of PetMed Express, Inc., was granted restricted stock awards and performance share units on June 26, 2026.

Nina Capital Holdings Inc. acquired 25,000 shares of PetMed Express (PETS) at an average price of $1.749 per share.

PetMed Express director Gian Fulgoni has terminated his service, resulting in the forfeiture of 26,057 restricted shares.

PetMed Express director Gian Fulgoni received a restricted stock award of 33,846 common shares, vesting in October 2026.

PetMed Express, Inc. granted its CAO and Interim CFO, Douglas Krulik, 20,000 restricted common stock shares as part of its 2024 Omnibus Incentive Plan.

PetMed Express Director James LaCamp received 34,866 restricted shares as part of the company's 2024 Omnibus Incentive Plan.

PETMED Express Director Justin L. Mennen received a restricted stock award of 33,846 shares, vesting in October 2026.

PETMED Express Director Leah Solivan received a restricted stock award of 33,846 shares, vesting in October 2026, increasing her beneficial ownership to 42,289 shares.

PetMed Express Director Peter Batushansky received a restricted stock award of 33,846 shares, vesting in October 2026.

PetMed Express's Chief Accounting Officer, Douglas Krulik, received a grant of 10,000 restricted common shares, vesting in six months.

PetMed Express, Inc. granted its Chief Accounting Officer, Douglas Krulik, 40,000 restricted stock units as part of its 2024 Inducement Incentive Plan.

Silvercape Investments, a director and 10% owner of PetMed Express Inc., reported the acquisition of 101,000 shares of common stock.

Silvercape Investments, a 10% owner and director, purchased 118,200 shares of PetMed Express Inc. common stock.

Nina Capital Holdings Inc., a 10% owner and director of PetMed Express Inc., along with affiliated directors, purchased 25,000 shares of common stock.

Silvercape Investments Ltd, a Director and 10% owner of PetMed Express Inc., has filed to acquire 17,565 shares of common stock at $3.23 per share on July 18, 2025, under a Rule 10b5-1 plan.

Silvercape Investments Ltd, a 10% owner and director, acquired 31,701 shares of PetMed Express Inc. common stock for $3.15 per share, increasing its beneficial ownership to 2,342,931 shares.

Silvercape Investments Ltd, a 10% owner and director, purchased an additional 2,817 shares of PetMed Express Inc. common stock at $3.22 per share, increasing its total beneficial ownership to 2,311,230 shares.

Silvercape Investments Ltd, a 10% owner and director of PetMed Express Inc., reported the acquisition of 694 shares of common stock at $3.21 per share, increasing its direct beneficial ownership to 2,308,413 shares.

An insider group, including Nina Capital Holdings Inc. and two directors, acquired 25,000 shares of PetMed Express common stock for approximately $98,375, increasing their total beneficial ownership to 2,550,000 shares.

A group of insiders, including Nina Capital Holdings Inc. and directors Moises Tache Galante and Stephannie Matz Zyman, collectively increased their beneficial ownership in PetMed Express Inc. by acquiring 25,000 shares of common stock.

Silvercape Investments Ltd, a 10% owner of PetMed Express Inc, acquired 7,401 shares of common stock at $3.95 per share on May 20, 2025, increasing its direct holdings to 2,307,719 shares.

Sandra Yvette Campos, CEO and President of PetMed Express, sold shares of common stock on April 30, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Director Peter Batushansky received 2,527 restricted stock units from PetMed Express, Inc. on April 9, 2025, which will vest on April 9, 2026, contingent upon continued service on the board.

Nina Capital Holdings, along with related parties, acquired 100,000 shares of PetMed Express Inc. at an average price of $4.085 per share, increasing their total holdings to 2,500,000 shares.

Nina Capital Holdings, along with related parties, reports the acquisition of 100,000 shares of PetMed Express Inc. at an average price of $4.11, increasing their total holdings to 2,400,000 shares.